Point-of-Care Testing (POCT) Market Research Analysis 2018 Top Companies are Medica Corporation, Nova Biomedical, Biomerica, Inc., Atlas Genetics, Accriva Diagnostics

Point-of-Care Testing (POCT) Market study with depth analysis, describing about the Service & Industry demand and explain market outlook and status to 2025. The market Study is segmented by key regions which are accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are dominating the Market by its Growth, Share Values and Many More

In 2017, blood glucose testing kits segment is expected to dominate the market with a share of around 27.0% and is expected to continue this trend till 2024.

To request a free sample copy or view summary of this report, click the link below @ http://databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market

According to new research report Global Point of Care Testing Market is anticipated to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

SIEMENS AG:

1. In November 2016, Siemens strengthened its healthcare business through public listing to give more focus and flexibility in pursuing its growth strategy.
2. In June 2016, Siemens opened a new headquarter in Munich to enhance its global presence in this market.

ABBOTT:

1. In May 2017, Abbott announced CE Mark approval and its use of the new Rx Insertable Cardiac Monitor (ICM), which is the world’s first smartphone compatible ICM to identify or detect cardiac arrhythmias, including atrial fibrillation (AF), for therapy.
2. In May 2017, Abbott announced the national reimbursement for freestyle Libre in France, providing access to revolutionary technology for people suffering with diabetes. This would help thousands of people to have access to test type 1 and type 2 diabetes.
3. In February 2017, FDA granted the use of Abbott Real Time Zika test product to detect Zika virus in whole blood samples for use of in vitro diagnostic tests during emergencies.

Any specific requirements are you looking for? Ask to your Industry Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market

TABLE OF CONTENTS GLOBAL POINT-OF-CARE TESTING MARKET

1. INTRODUCTION

2. MARKET SEGMENTATION

3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES

3.4.1. LACK OF ACCURACY AND EFFICIENCY
3.4.2. DATA MANAGEMENT AND LACK OF CONNECTIVITY
3.4.3. TESTING PERFORMED BY NON-LABORATORY PERSONNEL AND LACK OF AWARENESS AMONG THE USERS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL POINT-OF-CARE TESTING MARKET: REGULATORY SCENARIO

6.1. OVERVIEW:

6.1.1. REGULATORY PROCEDURE:

7. GLOBAL POINT-OF-CARE TESTING MARKET: REIMBURSEMENT SCENARIO

7.1. OVERVIEW:

8. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE

8.1. OVERVIEW

8.2. CARDIOMETABOLIC MONITORING KITS

8.2.1. CARDIAC MARKERS
8.2.2. BLOOD GAS ELECTROLYTE TESTING KITS
8.2.3. HBA1C TESTING KITS
8.2.4. LIPID TESTING KITS

8.3. INFECTIOUS DISEASE TESTING KITS

8.3.1. INFLUENZA TESTING KITS
8.3.2. HIV TESTING KITS
8.3.3. HEPATITIS TESTING KITS
8.3.4. STD TESTING KITS
8.3.5. TROPICAL DISEASESTESTING KITS
8.3.6. HEALTHCARE ASSOCIATED TESTING KITS
8.3.7. RESPIRATORY INFECTIONS TESTING KITS

8.4. CHOLESTEROL TESTING KITS

8.4.1. PROTHROMBIN TIME TESTING KITS
8.4.2. ACTIVATED CLOTTING TIME TESTING KITS

8.5. BLOOD GLUCOSE TESTING KITS

8.6. PREGNANCY AND FERTILITY TESTING KITS

8.7. TUMOR CANCER MARKERS

8.8. URINALYSIS TESTING KITS

8.9. HEMATOLOGY TESTING KITS

8.10. DRUGS OF ABUSE TESTING KITS

8.11. FECAL OCCULT TESTING KITS

8.12. RAPID COAGULATION TESTING KITS

9. GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL

9.1. OVERVIEW

9.1.1. DIRECT TENDER
9.1.2. RETAIL PHARMACY

10. GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER

10.1. OVERVIEW
10.2. GLOBAL POCT MARKET: HOSPITALS
10.3. GLOBAL POCT MARKET: CLINICS
10.4. GLOBAL POCT MARKET: AMBULATORY CARE
10.5. GLOBAL POCT MARKET: HOME HEALTHCARE
10.6. GLOBAL POCT MARKET: RESEARCH LABORATORIES

11. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE

11.1. OVERVIEW
11.2. GLOBAL POCT MARKET: PRESCRIPTION BASED TESTING KITS
11.3. GLOBAL POCT MARKET: OVER THE COUNTER BASED TESTING KITS

12. GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY

12.1. OVERVIEW

12.2. NORTH AMERICA POINT-OF-CARE TESTING MARKET

12.2.1. U.S.POINT-OF-CARE TESTING MARKET
12.2.2. CANADA POINT-OF-CARE TESTING MARKET
12.2.3. MEXICO POINT-OF-CARE TESTING MARKET

12.3. EUROPE POINT-OF-CARE TESTING MARKET

12.3.1. GERMANY POINT-OF-CARE TESTING MARKET
12.3.2. FRANCE POINT-OF-CARE TESTING MARKET
12.3.3. U.K. POINT-OF-CARE TESTING MARKET
12.3.4. ITALY POINT-OF-CARE TESTING MARKET
12.3.5. SPAIN POINT-OF-CARE TESTING MARKET
12.3.6. RUSSIA POINT-OF-CARE TESTING MARKET
12.3.7. TURKEY POINT-OF-CARE TESTING MARKET
12.3.8. BELGIUM POINT-OF-CARE TESTING MARKET
12.3.9. NETHERLANDS POINT-OF-CARE TESTING MARKET
12.3.10. SWITZERLAND POINT-OF-CARE TESTING MARKET
12.3.11. REST OF EUROPE POINT-OF-CARE TESTING MARKET

12.4. APAC POINT-OF-CARE TESTING MARKET

12.4.1. JAPAN POINT-OF-CARE TESTING MARKET
12.4.2. CHINA POINT-OF-CARE TESTING MARKET
12.4.3. SOUTH KOREA POINT-OF-CARE TESTING MARKET
12.4.4. INDIA POINT-OF-CARE TESTING MARKET
12.4.5. AUSTRALIA POINT-OF-CARE TESTING MARKET
12.4.6. SINGAPORE POINT-OF-CARE TESTING MARKET
12.4.7. THAILAND POINT-OF-CARE TESTING MARKET
12.4.8. MALAYSIA POINT-OF-CARE TESTING MARKET
12.4.9. INDONESIA POINT-OF-CARE TESTING MARKET
12.4.10. PHILIPPINES POINT-OF-CARE TESTING MARKET
12.4.11. REST OF APAC POINT-OF-CARE TESTING MARKET

12.5. MEA POINT-OF-CARE TESTING MARKET

12.5.1. SOUTH AFRICA POINT-OF-CARE TESTING MARKET
12.5.2. SAUDI ARABIA POINT-OF-CARE TESTING MARKET
12.5.3. UAE POINT-OF-CARE TESTING MARKET
12.5.4. REST OF MEA POINT-OF-CARE TESTING MARKET

12.6. SOUTH AMERICA POINT-OF-CARE TESTING MARKET

12.6.1. BRAZIL POINT-OF-CARE TESTING MARKET

13. GLOBAL POINT-OF-CARE TESTING MARKET : COMPANY LANDSCAPE

13.1. COMPANY SHARE ANALYSIS: GLOBAL
13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3. COMPANY SHARE ANALYSIS: EUROPE
13.4. COMPANY SHARE ANALYSIS: APAC

14. COMPANY PROFILES
14.1. JOHNSON AND JOHNSON SERVICES, INC.
14.2. BECTON, DICKINSON AND COMPANY
14.3. MEDTRONIC
14.4. F. HOFFMANN-LA ROCHE LTD
14.5. SIEMENS AG
14.6. ABBOTT
14.7. DANAHER
14.8. WERFENLIFE
14.9. HENRY SCHEIN, INC.
14.10. OPTI MEDICAL (SUBSIDIARY OF IDEXX LABORATORIES, INC)
14.11. SIENCO, INC.
14.12. ACON LABORATORIES, INC.

15. RELATED REPORTS

Browse Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=point-care-testing-poct-market

Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want.

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.